Press Resease

Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis

Alcoholic Hepatitis Therapeutics Market - By Product Type (Monoclonal Antibodies, Corticosteroids, Hemorheologic agents, Caspase protease inhibitor, Anabolic steroids, Sulfhydryl agents, and Hepatotropic Hormones), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 17-Aug-2021 Category: Healthcare Report Format : PDF Pages: 120 Report Code: ZMR-6600 Status : Published

The global Alcoholic Hepatitis Therapeutics market accrued earnings worth approximately 673 (USD Million) in 2020 and is predicted to gain revenue of about 1,013(USD Million) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

Description

The global Alcoholic Hepatitis Therapeutics market accrued earnings worth approximately 673 (USD Million) in 2020 and is predicted to gain revenue of about 1,013(USD Million) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028. The report offers assessment and analysis of the Alcoholic Hepatitis Therapeutics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Alcoholic Hepatitis Therapeutics Market: Synopsis

Alcoholic hepatitis is severe hepatic inflammation related to morbidity & mortality and occurs in persons consuming large proportion of alcohol. In addition to this, it is a syndrome in patients that causes acute chronic liver failure. Apparently, alterations in gut microbiota, cytokine signaling & inflammation, mitochondrial dysfunction, oxidative stress, and abnormities in hepatic regeneration capacity are predicted to contribute towards alcoholic hepatitis pathology. Furthermore, hospitalized alcoholic hepatitis patients result in massive healthcare expenditure and hence it is necessary for finding effective treatment for this ailment. Additionally, alcoholic hepatitis can affect gastrointestinal system, hematologic system, renal system, central nervous system, and cardiovascular system. It can injure hepatocyte and impair intestinal barrier activity. Symptoms of the alcoholic hepatitis include anorexia, fever, fatigue, weight loss, and right upper quadrant abdominal pain.

In addition to this, alcoholic hepatitis is a multisystem ailment that occurs due to intake of alcohol in huge quantities over an elongated period. Growth of the disease depends on ecological & genetic aspects. Key treatment for the disease includes abstinence from alcohol beverage consumption & supportive patient care. Moreover, corticosteroids are the most efficient medical treatment method but it can only improve rate of survival in selective group of patients for only a shorter period.  Reportedly, men consuming over 100 gram of ethanol regularly for more than five years are at high risk of getting affected from alcoholic hepatitis. While in case of women, ingesting of small proportion of ethanol for short term can cause alcoholic hepatitis. Some of other treatments for alcoholic hepatitis include nutritious food and use of medicines such as metadoxine, pentocifylline, and N-acetyl cysteine. Additionally, behavioral therapy, baclofen, and rehabilitation are some of the other therapies that are utilized in treating alcoholic hepatitis.  Other emerging treatments include probiotics, antibiotics, zinc, melatonin, FXR agonist, mycophenolate, emricasan, anakinra, mitoq, metadoxine, interleukin-22, and erythropoietin.

Alcoholic Hepatitis Therapeutics Market: Growth Factors

Surge in intake of alcohol and rise in alcoholic liver ailment will drive growth of alcoholic hepatitis therapeutic market. In addition to this, surging knowledge about pathophysiology of alcoholic hepatitis along with availability of substitute therapies will drive industry trends. For the record, nearly 56,809 hospital admissions with primary diagnosis of alcoholic hepatitis contributed nearly 0.71% of overall hospital admissions in the U.S. during 2007. Moreover, total hospitalization costs incurred on treating alcoholic hepatitis was more as compared to costs incurred on treatment of acute cerebrovascular ailment, acute myocardial infarction, and acute pancreatitis. This, in turn, will drive growth of alcoholic hepatitis therapeutics market size.

Furthermore, strong medicine pipeline is predicted to steer expansion of alcoholic hepatitis therapeutics market. In addition to this, rise in acceptance of new therapeutic medicines and increase in cases of liver transplantations in patients will further boost business trends.

Regional Landscape

North American Market To Record Exponential Growth During 2021-2028

Prominent market expansion in North America over forecast period can be attributed to robust healthcare sector and adoption of new drugs for treating alcoholic hepatitis. In addition to this, huge occurrence of disease in the region will further contribute towards alcoholic hepatitis therapeutics market value in North America over the upcoming years. In addition to this, presence of major drug producers for treating the disease in the sub-continent will steer regional market growth.

Competitive Landscape

Key players influencing market growth are Sanofi, Gilead Sciences, Inc., Immuron Limited, Generon Pharmaceutical Technology Company Limited, and Intercept Pharmaceuticals, Ltd.

The global Alcoholic Hepatitis Therapeutics Market is segmented as follows:

By Product Type

  • Monoclonal Antibodies
  • Corticosteroids
  • Hemorheologic agents
  • Caspase protease inhibitor
  • Anabolic steroids
  • Sulfhydryl agents
  • Hepatotropic Hormones

By Distribution Channel

  • Hospital Pharmacies
  • Retail  Pharmacies
  • Online Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Alcohulic Hepatitis Therapeutics Market, 2018–2028(USD Million)
    • 2.2. Alcohulic Hepatitis Therapeutics Market: Snapshot
  • Chapter 3. Global Alcohulic Hepatitis Therapeutics Market– Industry Analysis
    • 3.1. Alcohulic Hepatitis Therapeutics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rise in alcohulic beverage consumption and increase in occurrence of alcohulic liver disorders will expedite alcohulic hepatitis therapeutic market growth.
      • 3.2.2. Surging awareness about pathophysiulogy of alcohulic hepatitis and easy availing of substitute clinical treatments will inflate market revenue.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Product Type
      • 3.4.2. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Alcohulic Hepatitis Therapeutics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Alcohulic Hepatitis Therapeutics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Alcohulic Hepatitis Therapeutics Market– Product Type Analysis
    • 5.1. Global Alcohulic Hepatitis Therapeutics Market overview: By Product Type
      • 5.1.1. Global Alcohulic Hepatitis Therapeutics Market share, By Product Type, 2020 and 2028
    • 5.2. Monoclonal Antibodies
      • 5.2.1. Global Alcohulic Hepatitis Therapeutics Market by Monoclonal Antibodies, 2018–2028(USD Million)
    • 5.3. Corticosteroids
      • 5.3.1. Global Alcohulic Hepatitis Therapeutics Market by Corticosteroids, 2018–2028(USD Million)
    • 5.4. Hemorheulogic agents
      • 5.4.1. Global Alcohulic Hepatitis Therapeutics Market by Hemorheulogic agents, 2018–2028(USD Million)
    • 5.5. Caspase protease inhibitor
      • 5.5.1. Global Alcohulic Hepatitis Therapeutics Market by Caspase protease inhibitor, 2018–2028(USD Million)
    • 5.6. Anabulic steroids
      • 5.6.1. Global Alcohulic Hepatitis Therapeutics Market by Anabulic steroids, 2018–2028(USD Million)
    • 5.7. Sulfhydryl agents
      • 5.7.1. Global Alcohulic Hepatitis Therapeutics Market by Sulfhydryl agents, 2018–2028(USD Million)
    • 5.8. Hepatotropic Hormones
      • 5.8.1. Global Alcohulic Hepatitis Therapeutics Market by Hepatotropic Hormones, 2018–2028(USD Million)
  • Chapter 6. Global Alcohulic Hepatitis Therapeutics Market overview: By Distribution Channel
    • 6.1.1. Global Alcohulic Hepatitis Therapeutics Market share, By Distribution Channel, 2020 and 2028
    • 6.2. Hospital Pharmacies
      • 6.2.1. Global Alcohulic Hepatitis Therapeutics Market by Hospital Pharmacies , 2018–2028(USD Million)
    • 6.3. Retail Pharmacies
      • 6.3.1. Global Alcohulic Hepatitis Therapeutics Market by Retail Pharmacies, 2018–2028(USD Million)
    • 6.4. Online Pharmacies
      • 6.4.1. Global Alcohulic Hepatitis Therapeutics Market by Online Pharmacies, 2018–2028(USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Sanofi
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Immuron Limited
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Generon Pharmaceutical Technology Company Limited
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Intercept Pharmaceuticals, Ltd.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Gilead Sciences, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development

List of Figures

1. Market research Type
2. Market research methodology
3. Global Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Alcoholic Hepatitis Therapeutics Marketattractiveness, By Product Type
6. Global Alcoholic Hepatitis Therapeutics Marketattractiveness, By Distribution Channel
7. Global Alcoholic Hepatitis Therapeutics Marketshare by Product Type ,2020 and 2028 (USD Million)
8. Global Alcoholic Hepatitis Therapeutics Marketby Monoclonal Antibodies, 2018–2028(USD Million)
9. Global Alcoholic Hepatitis Therapeutics Marketby Corticosteroids, 2018–2028(USD Million)
10. Global Alcoholic Hepatitis Therapeutics Marketby Caspase protease inhibitor, 2018–2028(USD Million)
11. Global Alcoholic Hepatitis Therapeutics Marketby Anabolic steroids, 2018–2028(USD Million)
12. Global Alcoholic Hepatitis Therapeutics Marketby Sulfhydryl agents, 2018–2028(USD Million)
13. Global Alcoholic Hepatitis Therapeutics Marketby Hemorheologic agents, 2018–2028(USD Million)
14. Global Alcoholic Hepatitis Therapeutics Marketby and Hepatotropic Hormones, 2018–2028(USD Million)
15. Global Alcoholic Hepatitis Therapeutics Marketshare by Distribution Channel ,2020 and 2028 (USD Million)
16. Global Alcoholic Hepatitis Therapeutics Marketby Hospital Pharmacies,  2018–2028(USD Million)
17. Global Alcoholic Hepatitis Therapeutics Marketby Online Pharmacies, 2018–2028(USD Million)
18. Global Alcoholic Hepatitis Therapeutics Marketby Retail  Pharmacies, 2018–2028(USD Million)
19. Global Alcoholic Hepatitis Therapeutics Marketshare, by Region, 2020 and 2028
20. North America Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
21. Europe Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
22. Asia Pacific Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
23. Latin America Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
24. The Middle East and Africa Alcoholic Hepatitis Therapeutics Market, 2018–2028(USD Million)
 


List of Tables

1. Global Alcoholic Hepatitis Therapeutics Market: snapshot
2. Drivers of the Alcoholic Hepatitis Therapeutics Market: impact analysis
3. North America Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
4. North America Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
5. The U.S. Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
6. The U.S. Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
7. Rest of North America Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
8. Rest of North America Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
9. Europe Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
10. Europe Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
11. UK Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
12. UK Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
13. France Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
14. France Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
15. Germany Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
16. Germany Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
17. Rest of Europe Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
18. Rest of Europe Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
19. Asia Pacific Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
20. Asia Pacific Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
21. China Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
22. China Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
23. Japan Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
24. Japan Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
25. India Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
26. India Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
27. Rest of Asia Pacific Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
28. Rest of Asia Pacific Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
29. Latin America Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
30. Latin America Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
31. Brazil Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
32. Brazil Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
33. Rest of Latin America Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
34. Rest of Latin  America Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
35. The Middle East and Africa Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
36. The Middle East and Africa Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
37. Saudi Arabia Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
38. Saudi Arabia Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
39. South Africa Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
40. South Africa Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)
41. Rest of the Middle East & Africa Alcoholic Hepatitis Therapeutics Market revenue, By Product Type  ,2018–2028(USD Million)
42. Rest of the Middle East & Africa Alcoholic Hepatitis Therapeutics Market revenue, By Distribution Channel ,2018–2028(USD Million)

 
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Surge in intake of alcohol and rise in alcoholic liver ailment will drive growth of alcoholic hepatitis therapeutic market. In addition to this, surging knowledge about pathophysiology of alcoholic hepatitis along with availability of substitute therapies will drive business trends. For the record, nearly 56,809 hospital admissions with primary diagnosis of alcoholic hepatitis contributed nearly 0.71% of overall hospital admissions in the U.S. during 2007. Moreover, total hospitalization costs incurred on treating alcoholic hepatitis was more as compared to costs incurred on treatment of acute cerebrovascular ailment, acute myocardial infarction, and acute pancreatitis. This, in turn, will drive growth of alcoholic hepatitis therapeutics market size.

Furthermore, strong medicine pipeline is predicted to spur expansion of alcoholic hepatitis therapeutics market. In addition to this, rise in acceptance of new therapeutic medicines and increase in cases of liver transplantations in patients will further promulgate industry growth.

According to Zion market research report, the global Alcoholic Hepatitis Therapeutics market accrued earnings worth approximately 673 (USD Million) in 2020 and is predicted to gain revenue of about 1,013(USD Million) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to robust healthcare sector and acceptance of new drugs for treating alcoholic hepatitis. In addition to this, huge occurrence of disease in the region will further contribute towards alcoholic hepatitis therapeutics market value in North America over ensuing years. In addition to this, presence of major drug producers for treating the disease in the sub-continent will embellish regional market growth.

The key market participants include Sanofi, Gilead Sciences, Inc., Immuron Limited, Generon Pharmaceutical Technology Company Limited, and Intercept Pharmaceuticals, Ltd.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed